Trader Brian Jones@MasterBJones·Apr 21, 20204:06 pm ET *Immunic Reports That Its IMU-838 Has Demonstrated Preclinical Activity Against SARS-Coronavirus And Explores Plans For A Phase 2 Clinical Trial In Coronavirus Patients(Benzinga)48
Trader Brian Jones@MasterBJonesReplying to @bigdude2929$$$$$$$$$$$ Yaya!Translate Tweet8:46 PM · Apr 21, 2020·Twitter Web App